Cargando…

Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic progressive inflammatory disease of the esophagus, characterized by extracellular matrix remodeling and fibrotic stricture formation. Disease monitoring requires multiple re-endoscopies with esophageal biopsies. Hence non-invasive methods for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pehrsson, Martin, de Rooij, Willemijn E., Bay-Jensen, Anne-Christine, Karsdal, Morten Asser, Mortensen, Joachim Høg, Bredenoord, Albert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577915/
https://www.ncbi.nlm.nih.gov/pubmed/37845632
http://dx.doi.org/10.1186/s12876-023-02977-z
_version_ 1785121409382481920
author Pehrsson, Martin
de Rooij, Willemijn E.
Bay-Jensen, Anne-Christine
Karsdal, Morten Asser
Mortensen, Joachim Høg
Bredenoord, Albert Jan
author_facet Pehrsson, Martin
de Rooij, Willemijn E.
Bay-Jensen, Anne-Christine
Karsdal, Morten Asser
Mortensen, Joachim Høg
Bredenoord, Albert Jan
author_sort Pehrsson, Martin
collection PubMed
description BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic progressive inflammatory disease of the esophagus, characterized by extracellular matrix remodeling and fibrotic stricture formation. Disease monitoring requires multiple re-endoscopies with esophageal biopsies. Hence non-invasive methods for determining tissue fibrosis and treatment efficacy are warranted. AIMS: To investigate the ability of extracellular matrix proteins in serum as potential biomarkers of tissue remodeling and clinical, endoscopic, and histological disease outcomes in adult EoE patients. METHODS: Protein-fingerprint assays were used to measure neo-epitope specific fragments of collagen remodeling, human-neutrophil elastase degraded calprotectin, and citrullinated or non-citrullinated vimentin in the serum of an adult EoE-cohort. Biomarker analysis, symptoms, endoscopic features and histological disease activity (eosinophils(eos) per high-power-field(hpf)) were evaluated at baseline and after six weeks of dietary intervention. RESULTS: Patients with a baseline (Endoscopic Reference score) EREFS fibrosis subscore ≥ 2 presented with increased fibrolysis of cross-linked type III collagen (CTX-III) (p < 0.01), whereas low CTX-III levels were observed in patients achieving histological remission (< 15 eos/hpf) (vs. no histological remission (p < 0.05). Progression of endoscopic fibrosis after intervention was associated with increased levels of type-III (PRO-C3) and -VI collagen (PRO-C6) formation (all; p < 0.05). A baseline EREFS inflammatory subscore ≥ 2 correlated with higher neutrophilic activity (Cpa9-HNE) at week 6 (p < 0.05). Moreover, increased degradation of type-III (C3M) and -IV (C4M/PRO-C4) collagens were associated with remission of food impaction after intervention (all; p < 0.05). CONCLUSION: Serum extracellular matrix remodeling proteins demonstrated potential as surrogate biomarkers for assessing histological disease remission, endoscopic fibrosis, and remission of symptoms of food impaction after diet intervention in adult EoE patients.
format Online
Article
Text
id pubmed-10577915
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105779152023-10-17 Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis Pehrsson, Martin de Rooij, Willemijn E. Bay-Jensen, Anne-Christine Karsdal, Morten Asser Mortensen, Joachim Høg Bredenoord, Albert Jan BMC Gastroenterol Research BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic progressive inflammatory disease of the esophagus, characterized by extracellular matrix remodeling and fibrotic stricture formation. Disease monitoring requires multiple re-endoscopies with esophageal biopsies. Hence non-invasive methods for determining tissue fibrosis and treatment efficacy are warranted. AIMS: To investigate the ability of extracellular matrix proteins in serum as potential biomarkers of tissue remodeling and clinical, endoscopic, and histological disease outcomes in adult EoE patients. METHODS: Protein-fingerprint assays were used to measure neo-epitope specific fragments of collagen remodeling, human-neutrophil elastase degraded calprotectin, and citrullinated or non-citrullinated vimentin in the serum of an adult EoE-cohort. Biomarker analysis, symptoms, endoscopic features and histological disease activity (eosinophils(eos) per high-power-field(hpf)) were evaluated at baseline and after six weeks of dietary intervention. RESULTS: Patients with a baseline (Endoscopic Reference score) EREFS fibrosis subscore ≥ 2 presented with increased fibrolysis of cross-linked type III collagen (CTX-III) (p < 0.01), whereas low CTX-III levels were observed in patients achieving histological remission (< 15 eos/hpf) (vs. no histological remission (p < 0.05). Progression of endoscopic fibrosis after intervention was associated with increased levels of type-III (PRO-C3) and -VI collagen (PRO-C6) formation (all; p < 0.05). A baseline EREFS inflammatory subscore ≥ 2 correlated with higher neutrophilic activity (Cpa9-HNE) at week 6 (p < 0.05). Moreover, increased degradation of type-III (C3M) and -IV (C4M/PRO-C4) collagens were associated with remission of food impaction after intervention (all; p < 0.05). CONCLUSION: Serum extracellular matrix remodeling proteins demonstrated potential as surrogate biomarkers for assessing histological disease remission, endoscopic fibrosis, and remission of symptoms of food impaction after diet intervention in adult EoE patients. BioMed Central 2023-10-16 /pmc/articles/PMC10577915/ /pubmed/37845632 http://dx.doi.org/10.1186/s12876-023-02977-z Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pehrsson, Martin
de Rooij, Willemijn E.
Bay-Jensen, Anne-Christine
Karsdal, Morten Asser
Mortensen, Joachim Høg
Bredenoord, Albert Jan
Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
title Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
title_full Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
title_fullStr Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
title_full_unstemmed Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
title_short Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
title_sort extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577915/
https://www.ncbi.nlm.nih.gov/pubmed/37845632
http://dx.doi.org/10.1186/s12876-023-02977-z
work_keys_str_mv AT pehrssonmartin extracellularmatrixremodelingproteinsasbiomarkersforclinicalassessmentandtreatmentoutcomesineosinophilicesophagitis
AT derooijwillemijne extracellularmatrixremodelingproteinsasbiomarkersforclinicalassessmentandtreatmentoutcomesineosinophilicesophagitis
AT bayjensenannechristine extracellularmatrixremodelingproteinsasbiomarkersforclinicalassessmentandtreatmentoutcomesineosinophilicesophagitis
AT karsdalmortenasser extracellularmatrixremodelingproteinsasbiomarkersforclinicalassessmentandtreatmentoutcomesineosinophilicesophagitis
AT mortensenjoachimhøg extracellularmatrixremodelingproteinsasbiomarkersforclinicalassessmentandtreatmentoutcomesineosinophilicesophagitis
AT bredenoordalbertjan extracellularmatrixremodelingproteinsasbiomarkersforclinicalassessmentandtreatmentoutcomesineosinophilicesophagitis